| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |